Cardiac Function in Long-Term Survivors of Childhood Lymphoma

Table 2

Lymphoma characteristics and treatment data of survivors by lymphoma subtype.

Patient	Staging	Histology	ChemoTx	Irradiation	Total dose (cGy)	Mantle dose (cGy)
HL
1	3B	NONE	MOPP	MANTLE	1500	1500
2	2B	NS	MOPP	MANTLE	3000	3000
3	2B	NS	MOPP	MANTLE	4000	4000
4	1A	LP	MOPP	MANTLE	2000	2000
5	2B	LP	MOPP	MANTLE	4000	4000
6	3A	MC	MOPP/ABVD	TOT. NODAL	1650	1500
7	1A	NS	MOPP	MANTLE	2600	2800
8	2A	MC	MOPP/ABVD	MANTLE	2000	2000
9	2B	MC	MOPP/ABVD	MANTLE,INV.Y.SPLEEN	5800	4000
10	2A	NS	MOPP/ABVD	MANTLE	1800	1800
11	3B	NS	MOPP/ABVD	MANTLE,PARAAORTIC	8000	4000
12	2B	NS	MOPP/ABVD	MANTLE,INV.Y	4000	4000
13	2B	MC	MOPP/ABVD	MANTLE	3060	3060
14	3B	NS	MOPP	MANTLE,INV.Y,SPLEEN	5100	2500
15	2A	NONE	MOPP	MANTLE,INV.Y	8400	4400
16	2B-BULKY	MC	MOPP/ABVD	MANTLE	2600	2600
17	3A	NS	MOPP/ABVD	MANTLE	2600	2600
18	2A-BULKY	NS	MOPP/ABVD	MANTLE	4000	4000
19	1A	NS	MOPP/ABVD	MINIMANTLE	3600	3600
20	2A	NS	MOPP/ABVD	MANTLE	3000	3000
21	3B	LD	MOPP	MANTLE,INV.Y	8000	4000
22	2A	NS	MOPP	MANTLE	4000	4000
23	1A	LP	NONE	MANTLE	4000	4000
24	2A	NS	MOPP/ABVD	MANTLE	2600	2600
25	2A	NS	NONE	MANTLE,PARAO,SPLEEN	8000	4000
26	2B-BULKY	NS	MOPP/ABVD	MANTLE	3000	3000
Average					3935	3152
BL
27	NP	6	COMP		0	0
28	ABD	6	NCI		0	0
29	ABD	6	LMB		0	0
30	ABD	6	COMP		0	0
31	ABD	6	COMP		0	0
32	ABD	6	COMP		0	0
33	ABD	6	COM		0	0
34	ABD	6	COMP	WHOLE ABDOMEN	1550	0
35	ABD	6	NCI		0	0
36	ABD	6	LMB		0	0
37	NP	6	ACOMP		0	0
38	ABD	6	NCI		4000	0
Average					462	0
NHNB
39	0	7	LSAL2		0	0
40	0	7	LSAL2/COM	BRAIN,TOT.LUNG	3600	0
41	0	7	LSAL2	BRAIN,INV.Y	5600	0
42	0	7	COM		0	0
43	0	7	LSAL2	MEDIASTINUM	750	0
44	0	7	LSAL2	MEDIASTINUM	2000	0
45	0	7	COMP	BRAIN	2400	0
Average					2050	0

MOPP: nitrogen mustard, oncovin, prednisone, and procarbazine; COM/P: cyclophosphamide,oncovin, and methotrexate/prednisone; ABVD: adriamycin, bleomycin, vinblastine, and deticen; NCI: national cancer institute; ACOMP: like comp with adriamycine; LSA2L2: norma wollner protocol; LMB: no abbreviation; NS: nodular sclerosis; LP: lymphocyte predominance; MC: mixed cellularity; LD: lymphocyte depletion.